Literature DB >> 25378136

New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine.

Daniela Xhindoli1, Francesca Morgera1, Ursula Zinth2, Roberto Rizzo1, Sabrina Pacor1, Alessandro Tossi1.   

Abstract

The human cathelicidin peptide LL-37 is an important effector of our innate immune system and contributes to host defence with direct antimicrobial activity and immunomodulatory properties, and by stimulating wound healing. Its sequence has evolved to confer specific structural characteristics that strongly affect these biological activities, and differentiate it from orthologues of other primate species. In the present paper we report a detailed study of the folding and self-assembly of this peptide in comparison with rhesus monkey peptide RL-37, taking into account the different stages of its trajectory from bulk solution to contact with, and insertion into, biological membranes. Phenylalanine residues in different positions throughout the native sequences of LL-37 and RL-37 were systematically replaced with the non-invasive fluorescent and IR probe p-cyanophenylalanine. Steady-state and time-resolved fluorescence studies showed that LL-37, in contrast to RL-37, forms oligomers with a loose hydrophobic core in physiological solutions, which persist in the presence of biological membranes. Fourier transform IR and surface plasmon resonance studies also indicated different modes of interaction for LL-37 and RL-37 with anionic and neutral membranes. This correlated with a distinctly different mode of bacterial membrane permeabilization, as determined using a flow cytometric method involving impermeant fluorescent dyes linked to polymers of defined sizes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25378136     DOI: 10.1042/BJ20141016

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  Membrane Core-Specific Antimicrobial Action of Cathelicidin LL-37 Peptide Switches Between Pore and Nanofibre Formation.

Authors:  Mahdi Shahmiri; Marta Enciso; Christopher G Adda; Brian J Smith; Matthew A Perugini; Adam Mechler
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

Review 2.  Perspectives for clinical use of engineered human host defense antimicrobial peptides.

Authors:  María Eugenia Pachón-Ibáñez; Younes Smani; Jerónimo Pachón; Javier Sánchez-Céspedes
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

3.  Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.

Authors:  Ersilia De Lorenzi; Marcella Chiari; Raffaella Colombo; Marina Cretich; Laura Sola; Renzo Vanna; Paola Gagni; Federica Bisceglia; Carlo Morasso; Jennifer S Lin; Moonhee Lee; Patrick L McGeer; Annelise E Barron
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides.

Authors:  Federica Armas; Sabrina Pacor; Elena Ferrari; Filomena Guida; Thelma A Pertinhez; Antonello A Romani; Marco Scocchi; Monica Benincasa
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

5.  Antimicrobial Peptide LL-37 Facilitates Intracellular Uptake of RNA Aptamer Apt 21-2 Without Inducing an Inflammatory or Interferon Response.

Authors:  Tom Macleod; Joseph Ward; Adewonuola A Alase; Charlie Bridgewood; Miriam Wittmann; Nicola J Stonehouse
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

Review 6.  Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.

Authors:  Kornelius Zeth; Enea Sancho-Vaello
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

7.  Single-molecule visualization of dynamic transitions of pore-forming peptides among multiple transmembrane positions.

Authors:  Ying Li; Zhenyu Qian; Li Ma; Shuxin Hu; Daguan Nong; Chunhua Xu; Fangfu Ye; Ying Lu; Guanghong Wei; Ming Li
Journal:  Nat Commun       Date:  2016-09-30       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.